Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 53 out of 100. Down syndrome and Alzheimer's

Topic: Risk, prevention and care in population studies

Purpose Epilepsy and early-onset Alzheimer disease (AD) are both common in adults with Down syndrome (DS), and their temporal relationship remains unclear. We examined whether a recorded diagnosis of epilepsy was associated with higher subsequent recording of all-cause dementia, AD, non-Alzheimer dementia, and mortality among adults with DS aged 40 years or older. Methods Retrospective cohort study using deidentified electronic health records from the TriNetX Global Collaborative Network. Adults with DS (ICD-10-CM Q90; age ≥40 years; 2010-2025) were classified as having epilepsy (G40 recorded before any dementia code) or not; secondary seizures were excluded. Cohorts were balanced by 1:1 propensity score matching. Outcomes were assessed from 90 to 730 days after the index date using hazard ratios (HRs) and Kaplan-Meier analyses. Results After matching, 1812 patients per cohort were retained (mean [SD] age, 54.3 [7.0] vs 54.2 [7.4] years). Epilepsy was associated with higher subsequent recording of all-cause dementia (12.9%vs 6.5%; HR, 2.03 [95% CI, 1.59-2.60]), AD (6.1%vs 3.2%; HR, 1.97 [1.41-2.76]), non-Alzheimer dementia (12.9%vs 6.3%; HR, 2.08 [1.63-2.65]), and mortality (12.8%vs 5.1%; HR, 2.55 [2.00-3.24]). Estimates were similar by age and sex, and when exposure required an antiseizure medication prescription alongside the diagnostic code. Conclusion Epilepsy was associated with higher subsequent recording of dementia and mortality over 2 years. No biomarker, neuroimaging, or neuropathological measure was available; the estimates describe the order in which diagnoses were documented and do not establish that epilepsy marks the underlying neurodegenerative process. Differential ascertainment and residual confounding remain plausible contributors.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Pereira da Silva, A. M., Tudella, G. C. N., Lee, A. M., Santos, D. H., Cukiert, C. M., & Perry, G. (2026). Epilepsy and subsequent dementia in adults with down syndrome: a propensity score-matched cohort study using federated electronic health records. Seizure. https://doi.org/10.1016/j.seizure.2026.08.023

Vancouver

Pereira da Silva AM, Tudella GCN, Lee AM, Santos DH, Cukiert CM, Perry G. Epilepsy and subsequent dementia in adults with down syndrome: a propensity score-matched cohort study using federated electronic health records. Seizure. 2026. doi:10.1016/j.seizure.2026.08.023. PMID: 42721539.

BibTeX

@article{pereiradasilva2026-42721539,
  author  = {Pereira da Silva, A. M. and Tudella, G. C. N. and Lee, A. M. and Santos, D. H. and Cukiert, C. M. and Perry, G.},
  title   = {{Epilepsy and subsequent dementia in adults with down syndrome: a propensity score-matched cohort study using federated electronic health records}},
  journal = {Seizure},
  year    = {2026},
  doi     = {10.1016/j.seizure.2026.08.023},
  pmid    = {42721539},
  url     = {https://doi.org/10.1016/j.seizure.2026.08.023}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

In this matched cohort of adults with Down syndrome, a recorded epilepsy diagnosis was associated with higher later recording of all-cause dementia, Alzheimer's disease, non-Alzheimer dementia, and mortality. It is an observational association and does not show that treating epilepsy would prevent dementia.

Study details

How this study scored 53/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 3 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 4 of 4; Institution's track record 0 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 53 of 100.53 of 100 points earned47 not earned

Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Seizure)
Journal's citation record 1 / 4 Seizure: journal h-index 124 (OpenAlex, 2026-10-29)
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 3 / 4 1,812 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year 3 / 6 Cited 6.4× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author George L. Perry: h-index 154 (OpenAlex, whole career)
Institution's track record 0 / 3 Universidade Federal de Minas Gerais: institution h-index 527 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 5 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42721539)
Free to read 0 / 2 Behind a paywall — scores zero
Total 53 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Down syndrome and Alzheimer's

Also tagged “down”

527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Down syndrome and Alzheimer's

See all studies in Down syndrome and Alzheimer's →